| Structure of an aromatic-ring-hydroxylating dioxygenase–naphthalene 1, 2-dioxygenase B Kauppi, K Lee, E Carredano, RE Parales, DT Gibson, H Eklund, ... Structure 6 (5), 571-586, 1998 | 663 | 1998 |
| The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to … B Kauppi, C Jakob, M Färnegårdh, J Yang, H Ahola, M Alarcon, ... Journal of Biological Chemistry 278 (25), 22748-22754, 2003 | 406 | 2003 |
| Substrate binding site of naphthalene 1, 2-dioxygenase: functional implications of indole binding E Carredano, A Karlsson, B Kauppi, D Choudhury, RE Parales, ... Journal of molecular biology 296 (2), 701-712, 2000 | 217 | 2000 |
| The Three-dimensional Structure of Mammalian Ribonucleotide Reductase Protein R2 Reveals a More-accessible Iron-radical Site thanEscherichia coliR2 B Kauppi, BB Nielsen, S Ramaswamy, IK Larsen, M Thelander, ... Journal of molecular biology 262 (5), 706-720, 1996 | 168 | 1996 |
| Liver-selective glucocorticoid antagonists: a novel treatment for type 2 diabetes TW von Geldern, N Tu, PR Kym, JT Link, HS Jae, C Lai, T Apelqvist, ... Journal of medicinal chemistry 47 (17), 4213-4230, 2004 | 90 | 2004 |
| The irreversible inactivation of ribonucleotide reductase from Escherichia coli by superoxide radicals P Gaudu, V Nivière, Y Pétillot, B Kauppi, M Fontecave FEBS letters 387 (2-3), 137-140, 1996 | 39 | 1996 |
| Purification and crystallization of the oxygenase component of naphthalene dioxygenase in native and selenomethionine-derivatized forms K Lee, B Kauppi, RE Parales, DT Gibson, S Ramaswamy Biochemical and biophysical research communications 241 (2), 553-557, 1997 | 29 | 1997 |
| Reactivity of the Tyrosyl Radical of Escherichia Coli Ribonucleotide Reductase: Control by the Protein C Gerez, E Elleingand, B Kauppi, H Eklund, M Fontecave European journal of biochemistry 249 (2), 401-407, 1997 | 22 | 1997 |
| Crystallization and crystallographic investigations of the small subunit of mouse ribonucleotide reductase BB Nielsen, B Kauppi, M Thelander, L Thelander, IK Larsen, H Eklund FEBS letters 373 (3), 310-312, 1995 | 19 | 1995 |
| Pseudo-symmetry characterization and refinement of a trigonal crystal form of naphthalene 1, 2-dioxygenase E Carredano, B Kauppi, D Choudhury, S Ramaswamy Acta Crystallographica Section D: Biological Crystallography 56 (3), 313-321, 2000 | 6 | 2000 |
| Structure of an aromatic-ring-hydroxylating dioxygenase-naphthalene 1, 2-dioxygenase, Structure6, 571− 586 B Kauppi, K Lee, E Carredano, RE Parales, DT Gibson, H Eklund, ... Google Scholar There is no corresponding record for this reference, 1998 | 4 | 1998 |
| Liver-Selective Glucocorticoid Antagonists: A Novel Treatment for Type 2 Diabetes. TW von Geldern, N Tu, PR Kym, JT Link, HS Jae, C Lai, T Apelqvist, ... Journal of Medicinal Chemistry 48 (7), 2724-2724, 2005 | 3 | 2005 |
| Implications for substrate specificity of naphthalene 1, 2-dioxygenase from the refined crystal structure E Carredano, B Kauppi, D Choudhury, RE Parales, K Lee, DT Gibson, ... Journal of Inorganic Biochemistry 74 (1-4), 21-21, 1999 | 3 | 1999 |
| PROTEIN STRUCTURE AND FOLDING-The Three-dimensional Structures of Antagonistic and Agonistic Forms of the Glucocorticoid Receptor Ligand-binding Domain. RU-486 INDUCES A … B Kauppi, C Jakob, M Farnegardh, J Yang, H Ahola, M Alarcon, K Calles, ... Journal of Biological Chemistry 278 (25), 22748-22754, 2003 | | 2003 |
| The antagonistic crystal structure of the glucocorticoid receptor, ligand-binding domain B Kauppi, C Jakob, M Farnegardh, H Ahola, M Alarcon, K Calles, ... Acta Crystallographica Section A 58, c201-c201, 2002 | | 2002 |
| Full wwPDB X-ray Structure Validation Report i○ B Kauppi, C Jakob, M Farnegardh, J Yang, H Ahola, M Alarcon, K Calles, ... | | |
| Full wwPDB X-ray Structure Validation Report i○ JD Bartho, D Bellini, J Wuerges, N Demitri, M Walsh, S Benini | | |
